Inhibition of Mer and Axl receptor tyrosine kinases leads to increased apoptosis and improved chemosensitivity in human neuroblastoma
Authors:
- 1 February 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 457 (3) , 461-466
Abstract
No abstract availableKeywords
Funding Information
- Jinan Young Star of Science and Technology Program (20110322)
This publication has 21 references indexed in Scilit:
- Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced ActivationJournal of Biological Chemistry, 2014
- Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer TherapiesInternational Journal of Molecular Sciences, 2014
- MerTK inhibition is a novel therapeutic approach for glioblastoma multiformeOncotarget, 2014
- TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous systemBrain Research, 2013
- Neuroblastoma in adolescents: genetic and clinical characterisationClinical and Translational Oncology, 2010
- Activating mutations in ALK provide a therapeutic target in neuroblastomaNature, 2008
- NeuroblastomaThe Lancet, 2007
- The Phox2B homeobox gene is mutated in sporadic neuroblastomasOncogene, 2004
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984